Objectives: To assess the effectiveness of Nicotinamide Adenine Dinucleotide (NAD) as brightening agent
Introduction: Hyperpigmentation from UV-induced melanogenesis contributes to conditions like melasma, PIH, and uneven skin tone. Conventional brightening agents—such as niacinamide, cysteamine, alpha-arbutin, 2-mercaptonicotinoyl glycine, and isobutylamido thiazolyl resorcinol primarily inhibit tyrosinase or melanin intermediates, but often face limitations like irritation or instability. NAD⁺ (nicotinamide adenine dinucleotide), a key coenzyme in cellular energy and DNA repair, also activates sirtuins, PARPs, and redox enzymes—core regulators of oxidative stress, inflammation, and epigenetic balance. These
Materials / method: A randomized, single-blind study in 33 participants used a UV-induced melanization model on the back. Seven formulations were applied twice daily for 4 weeks: Placebo, 0.1% NAD+, 10% Niacinamide, 2.5% Encapsulated Cysteamine, 2% Alpha-Arbutin, Commercial serum with 2-MNG, Commercial serum with isobutylamido thiazolyl resorcinol. Assessments were conducted after 4 weeks on parameters: ITA° (Individual Typology Angle, CM26-dG), Melanin index (Mexameter® MX18), Visual grading by board-certified dermatologists
Results: All treatments showed statistically significant improvement over placebo (p < 0.05). ITA° gains were highest with NAD+ (+16.1%), followed by niacinamide (+13.5%), cysteamine (+13.3%), alpha-arbutin (+12.8%), Thiamidol (+11.7%), and 2-MNG (+9.3%) versus placebo (+11%). In melanin index reduction, niacinamide (-12.5) was strongest, followed by cysteamine (-11.9), isobutylamido thiazolyl resorcinol (-11.8), NAD+ (-11.6), alpha-arbutin (-11.0), and placebo (-10.6). For visual grading, alpha-arbutin (-20.4) and niacinamide (-18.5) showed the greatest clinical brightening, followed closely by NAD+ (
Conclusion: Topical 0.1% NAD+ demonstrated superior improvement in ITA° and comparable reductions in melanin index and clinical pigmentation versus benchmark actives. With its multi-pathway mechanism, excellent tolerability, and statistically validated efficacy, NAD+ emerges as a promising innovation in the treatment of hyperpigmentation and skin tone correction.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Sim
Por favor indique a entidade (pessoa ou empresa): Labore
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Sim
Por favor informe a data...: Patent Pending
e o status: 28 May 2025
Este trabalho foi realizado com o patrocínio de: LABORE